scholarly journals Estimating the proportion of disease heritability mediated by gene expression levels

2017 ◽  
Author(s):  
Luke J. O’Connor ◽  
Alexander Gusev ◽  
Xuanyao Liu ◽  
Po-Ru Loh ◽  
Hilary K. Finucane ◽  
...  
Keyword(s):  
Gene Expression ◽  
Complex Traits ◽  
Disease Risk ◽  
Genetic Component ◽  
Effect Sizes ◽  
Expression Levels ◽  
Risk Variants ◽  
Regulatory Effects ◽  
Disease Effect ◽  
Gene Expression Levels

AbstractDisease risk variants identified by GWAS are predominantly noncoding, suggesting that gene regulation plays an important role. eQTL studies in unaffected individuals are often used to link disease-associated variants with the genes they regulate, relying on the hypothesis that noncoding regulatory effects are mediated by steady-state expression levels. To test this hypothesis, we developed a method to estimate the proportion of disease heritability mediated by the cis-genetic component of assayed gene expression levels. The method, gene expression co-score regression (GECS regression), relies on the idea that, for a gene whose expression level affects a phenotype, SNPs with similar effects on the expression of that gene will have similar phenotypic effects. In order to distinguish directional effects mediated by gene expression from non-directional pleiotropic or tagging effects, GECS regression operates on pairs of cis SNPs in linkage equilibrium, regressing pairwise products of disease effect sizes on products of cis-eQTL effect sizes. We verified that GECS regression produces robust estimates of mediated effects in simulations. We applied the method to eQTL data in 44 tissues from the GTEx consortium (average NeQTL = 158 samples) in conjunction with GWAS summary statistics for 30 diseases and complex traits (average NGWAS = 88K) with low pairwise genetic correlation, estimating the proportion of SNP-heritability mediated by the cis-genetic component of assayed gene expression in the union of the 44 tissues. The mean estimate was 0.21 (s.e. = 0.01) across 30 traits, with a significantly positive estimate (p < 0.001) for every trait. Thus, assayed gene expression in bulk tissues mediates a statistically significant but modest proportion of disease heritability, motivating the development of additional assays to capture regulatory effects and the use of our method to estimate how much disease heritability they mediate.

scholarly journals Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

2014 ◽  
Vol 6 (4) ◽  
pp. 39 ◽  
Author(s):  
Mariet Allen ◽  
Michaela Kachadoorian ◽  
Zachary Quicksall ◽  
Fanggeng Zou ◽  
High Chai ◽  
...  
Keyword(s):  
Gene Expression ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Disease Risk ◽  
Expression Levels ◽  
Brain Gene Expression ◽  
Gene Expression Levels

scholarly journals Integrative genomic strategies applied to a lymphoblast cell line model reveal specific transcriptomic signatures associated with clozapine response

2020 ◽  
Author(s):  
SAJ de With ◽  
APS Ori ◽  
T Wang ◽  
SL Pulit ◽  
E Strengman ◽  
...  
Keyword(s):  
Gene Expression ◽  
Dna Methylation ◽  
Adverse Effects ◽  
Drug Targets ◽  
Molecular Mechanisms ◽  
Disease Risk ◽  
Density Lipoprotein ◽  
Expression Levels ◽  
Genome Wide ◽  
Gene Expression Levels

AbstractClozapine is an important antipsychotic drug. However, its use is often accompanied by metabolic adverse effects and, in rare instances, agranulocytosis. The molecular mechanisms underlying these adverse events are unclear. To gain more insights into the response to clozapine at the molecular level, we exposed lymphoblastoid cell lines (LCLs) to increasing concentrations of clozapine and measured genome-wide gene expression and DNA methylation profiles. We observed robust and significant changes in gene expression levels due to clozapine (n = 463 genes at FDR < 0.05) affecting cholesterol and cell cycle pathways. At the level of DNA methylation, we find significant changes upstream of the LDL receptor, in addition to global enrichments of regulatory, immune and developmental pathways. By integrating these data with human tissue gene expression levels obtained from the Genotype-Tissue Expression project (GTEx), we identified specific tissues, including liver and several tissues involved in immune, endocrine and metabolic functions, that clozapine treatment may disproportionately affect. Notably, differentially expressed genes were not enriched for genome-wide disease risk of schizophrenia or for known psychotropic drug targets. However, we did observe a nominally significant association of genetic signals related to total cholesterol and low-density lipoprotein levels. Together, these results shed light on the biological mechanisms through which clozapine functions. The observed associations with cholesterol pathways, its genetic architecture and specific tissue effects may be indicative of the metabolic adverse effects observed in clozapine users. LCLs may thus serve as a useful tool to study these molecular mechanisms further.

scholarly journals LORSEN: Fast and Efficient eQTL Mapping With Low Rank Penalized Regression

2021 ◽  
Vol 12 ◽  
Author(s):  
Cheng Gao ◽  
Hairong Wei ◽  
Kui Zhang
Keyword(s):  
Gene Expression ◽  
Complex Traits ◽  
Large Scale ◽  
Penalized Regression ◽  
Low Rank ◽  
Eqtl Mapping ◽  
Nucleotide Polymorphisms ◽  
Cellular Mechanisms ◽  
Expression Levels ◽  
Gene Expression Levels

Characterization of genetic variations that are associated with gene expression levels is essential to understand cellular mechanisms that underline human complex traits. Expression quantitative trait loci (eQTL) mapping attempts to identify genetic variants, such as single nucleotide polymorphisms (SNPs), that affect the expression of one or more genes. With the availability of a large volume of gene expression data, it is necessary and important to develop fast and efficient statistical and computational methods to perform eQTL mapping for such large scale data. In this paper, we proposed a new method, the low rank penalized regression method (LORSEN), for eQTL mapping. We evaluated and compared the performance of LORSEN with two existing methods for eQTL mapping using extensive simulations as well as real data from the HapMap3 project. Simulation studies showed that our method outperformed two commonly used methods for eQTL mapping, LORS and FastLORS, in many scenarios in terms of area under the curve (AUC). We illustrated the usefulness of our method by applying it to SNP variants data and gene expression levels on four chromosomes from the HapMap3 Project.

scholarly journals Rare Genetic Variants Underlie Outlying levels of DNA Methylation and Gene-Expression

2020 ◽  
Author(s):  
V. Kartik Chundru ◽  
Riccardo E. Marioni ◽  
James G. D. Pendergast ◽  
Tian Lin ◽  
Allan J. Beveridge ◽  
...  
Keyword(s):  
Gene Expression ◽  
Dna Methylation ◽  
Phenotypic Variation ◽  
Genetic Variants ◽  
Rare Variants ◽  
Effect Sizes ◽  
Expression Levels ◽  
Low Level ◽  
Rare Genetic Variants ◽  
Gene Expression Levels

AbstractTesting the effect of rare variants on phenotypic variation is difficult due to the need for extremely large cohorts to identify associated variants given expected effect sizes. An alternative approach is to investigate the effect of rare genetic variants on low-level genomic traits, such as gene expression or DNA methylation (DNAm), as effect sizes are expected to be larger for low-level compared to higher-order complex traits. Here, we investigate DNAm in healthy ageing populations - the Lothian Birth cohorts of 1921 and 1936 and identify both transient and stable outlying DNAm levels across the genome. We find an enrichment of rare genetic variants within 1kb of DNAm sites in individuals with stable outlying DNAm, implying genetic control of this extreme variation. Using a family-based cohort, the Brisbane Systems Genetics Study, we observed increased sharing of DNAm outliers among more closely related individuals, consistent with these outliers being driven by rare genetic variation. We demonstrated that outlying DNAm levels have a functional consequence on gene expression levels, with extreme levels of DNAm being associated with gene expression levels towards the tails of the population distribution. Overall, this study demonstrates the role of rare variants in the phenotypic variation of low-level genomic traits, and the effect of extreme levels of DNAm on gene expression.

scholarly journals Quantifying genetic effects on disease mediated by assayed gene expression levels

2019 ◽  
Author(s):  
Douglas W. Yao ◽  
Luke J. O’Connor ◽  
Alkes L. Price ◽  
Alexander Gusev
Keyword(s):  
Gene Expression ◽  
Steady State ◽  
Genetic Effects ◽  
Genetic Component ◽  
Specific Gene ◽  
Genome Wide Association Studies ◽  
Expression Levels ◽  
Gene Sets ◽  
Wide Range ◽  
Gene Expression Levels

AbstractDisease variants identified by genome-wide association studies (GWAS) tend to overlap with expression quantitative trait loci (eQTLs). However, it remains unclear whether this overlap is driven by mediation of genetic effects on disease by expression levels, or whether it primarily reflects pleiotropic relationships instead. Here we introduce a new method, mediated expression score regression (MESC), to estimate disease heritability mediated by the cis-genetic component of assayed steady-state gene expression levels, using summary association statistics from GWAS and eQTL studies. We show that MESC produces robust estimates of expression-mediated heritability across a wide range of simulations. We applied MESC to GWAS summary statistics for 42 diseases and complex traits (average N = 323K) and cis-eQTL data across 48 tissues from the GTEx consortium. We determined that a statistically significant but low proportion of disease heritability (mean estimate 11% with S.E. 2%) is mediated by the cis-genetic component of assayed gene expression levels, with substantial variation across diseases (point estimates from 0% to 38%). We further partitioned expression-mediated heritability across various gene sets. We observed an inverse relationship between cis-heritability of expression and disease heritability mediated by expression, suggesting that genes with weaker eQTLs have larger causal effects on disease. Moreover, we observed broad patterns of expression-mediated heritability enrichment across functional gene sets that implicate specific gene sets in disease, including loss-of-function intolerant genes and FDA-approved drug targets. Our results demonstrate that eQTLs estimated from steady-state expression levels in bulk tissues are informative of regulatory disease mechanisms, but that such eQTLs are insufficient to explain the majority of disease heritability. Instead, additional assays are necessary to more fully capture the regulatory effects of GWAS variants.

scholarly journals Diverse environmental perturbations reveal the evolution and context-dependency of genetic effects on gene expression levels

2021 ◽  
Author(s):  
Amanda J Lea ◽  
Julie Peng ◽  
Julien J Ayroles
Keyword(s):  
Gene Expression ◽  
Complex Traits ◽  
Large Scale ◽  
Context Dependency ◽  
Human Populations ◽  
Evolutionary Mechanisms ◽  
Expression Levels ◽  
Gxe Interactions ◽  
Context Dependent ◽  
Gene Expression Levels

There is increasing appreciation that human complex traits are determined by poorly understood interactions between our genomes and daily environments. These "genotype x environment" (GxE) interactions remain difficult to map at the organismal level, but can be uncovered using molecular phenotypes. To do so at large-scale, we profiled transcriptomes across 12 cellular environments using 544 immortalized B cell lines from the 1000 Genomes Project. We mapped the genetic basis of gene expression across environments and revealed a context-dependent genetic architecture: the average heritability of gene expression levels increased in treatment relative to control conditions and, on average, each treatment revealed expression quantitative trait loci (eQTL) at 11% of genes. In total, 22% of all eQTL were context-dependent, and this group was enriched for trait- and disease-associated loci. Further, evolutionary analyses revealed that positive selection has shaped GxE loci involved in responding to immune challenges and hormones, but not man-made chemicals, suggesting there is reduced opportunity for selection to act on responses to molecules recently introduced into human environments. Together, our work highlights the importance of considering an exposure's evolutionary history when studying and interpreting GxE interactions, and provides new insight into the evolutionary mechanisms that maintain GxE loci in human populations.

scholarly journals Autoimmune risk variants in ERAP2 are associated with gene-expression levels in thymus

2016 ◽  
Vol 17 (7) ◽  
pp. 406-411 ◽  
Author(s):  
I S M Gabrielsen ◽  
M K Viken ◽  
S S Amundsen ◽  
H Helgeland ◽  
K Holm ◽  
...  
Keyword(s):  
Gene Expression ◽  
Expression Levels ◽  
Risk Variants ◽  
Gene Expression Levels

scholarly journals A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis

Genes ◽  
2021 ◽  
Vol 12 (6) ◽  
pp. 854
Author(s):  
Yishu Wang ◽  
Lingyun Xu ◽  
Dongmei Ai
Keyword(s):  
Gene Expression ◽  
Gastric Cancer ◽  
Dna Methylation ◽  
Regression Model ◽  
The Cancer Genome Atlas ◽  
Low Rank ◽  
Expression Levels ◽  
Rank Regression ◽  
Prediction Of Prognosis ◽  
Gene Expression Levels

DNA methylation is an important regulator of gene expression that can influence tumor heterogeneity and shows weak and varying expression levels among different genes. Gastric cancer (GC) is a highly heterogeneous cancer of the digestive system with a high mortality rate worldwide. The heterogeneous subtypes of GC lead to different prognoses. In this study, we explored the relationships between DNA methylation and gene expression levels by introducing a sparse low-rank regression model based on a GC dataset with 375 tumor samples and 32 normal samples from The Cancer Genome Atlas database. Differences in the DNA methylation levels and sites were found to be associated with differences in the expressed genes related to GC development. Overall, 29 methylation-driven genes were found to be related to the GC subtypes, and in the prognostic model, we explored five prognoses related to the methylation sites. Finally, based on a low-rank matrix, seven subgroups were identified with different methylation statuses. These specific classifications based on DNA methylation levels may help to account for heterogeneity and aid in personalized treatments.

Sign in / Sign up

Export Citation Format

Share Document